| Scholar Rock Holding Corporation | 689K | US$33.3M | 5.9% |
| Erasca, Inc. | 2.26M | US$33.1M | 5.9% |
| Abivax SA | 279K | US$27.7M | 4.9% |
| Tango Therapeutics, Inc. | 989K | US$24.7M | 4.4% |
| Roivant Sciences Ltd. | 641K | US$23.5M | 4.2% |
| First Tracks Biotherapeutics, Inc. | 650K | US$23M | 4.1% |
| Enliven Therapeutics, Inc. | 330K | US$15.1M | 2.7% |
| Adaptive Biotechnologies Corporation | 464K | US$13.4M | 2.4% |
| Dianthus Therapeutics, Inc. | 151K | US$13.3M | 2.4% |
| Sensei Biotherapeutics, Inc. | 405K | US$12M | 2.2% |
| Spyre Therapeutics, Inc. | 132K | US$11.8M | 2.1% |
| GRAIL, Inc. | 81,924 | US$11.5M | 2.1% |
| Praxis Precision Medicines, Inc. | 38,720 | US$11.3M | 2.0% |
| Surrozen, Inc. | 419K | US$11.1M | 2.0% |
| C4 Therapeutics, Inc. | 3.29M | US$11M | 2.0% |
| Aclaris Therapeutics, Inc. | 2.05M | US$10.8M | 1.9% |
| Revolution Medicines, Inc. | 50,000 | US$10.3M | 1.8% |
| Cytokinetics, Incorporated | 146K | US$9.61M | 1.7% |
| BeOne Medicines Ltd. Class A | 25,051 | US$9.17M | 1.6% |
| Xenon Pharmaceuticals Inc. | 222K | US$8.27M | 1.5% |
| Johnson & Johnson | 30,000 | US$7.94M | 1.4% |
| Trevi Therapeutics, Inc. | 552K | US$7.91M | 1.4% |
| Eli Lilly and Company | 6,599 | US$7.64M | 1.4% |
| Arrowhead Pharmaceuticals, Inc. | 110K | US$7.19M | 1.3% |
| Cerus Corporation | 2.97M | US$7.06M | 1.3% |
| Immunovant, Inc. | 201K | US$6.8M | 1.2% |
| Jade Biosciences, Inc. | 472K | US$6.63M | 1.2% |
| Guardant Health, Inc. | 33,527 | US$5.98M | 1.1% |
| OmniAb, Inc. | 1.2M | US$5.97M | 1.1% |
| Cogent Biosciences, Inc. | 184K | US$5.9M | 1.1% |
| Biohaven Ltd. | 397K | US$5.3M | 0.95% |
| Mineralys Therapeutics, Inc. | 200K | US$5.03M | 0.90% |
| IDEAYA Biosciences, Inc. | 124K | US$4.75M | 0.85% |
| Celcuity Inc. | 57,880 | US$4.6M | 0.82% |
| Edgewise Therapeutics, Inc. | 112K | US$4.53M | 0.81% |
| Century Therapeutics, Inc. | 2.56M | US$4.38M | 0.78% |
| Biodesix, Inc. | 142K | US$4.22M | 0.75% |
| BioNTech SE | 42,200 | US$4.15M | 0.74% |
| Sanofi SA | 99,880 | US$4.12M | 0.74% |
| Aura Biosciences, Inc. | 647K | US$4.07M | 0.73% |
| CG Oncology, Inc. | 54,791 | US$3.88M | 0.69% |
| Viridian Therapeutics, Inc. | 187K | US$3.86M | 0.69% |
| Vor Biopharma Inc. | 201K | US$3.83M | 0.68% |
| LB Pharmaceuticals Inc | 91,757 | US$3.47M | 0.62% |
| Edesa Biotech, Inc. | 825K | US$3.47M | 0.62% |
| Avalyn Pharma Inc. | 118K | US$3.36M | 0.60% |
| Intuitive Surgical, Inc. | 8,087 | US$3.29M | 0.59% |
| Nurix Therapeutics, Inc. | 138K | US$3.27M | 0.58% |
| Ovid Therapeutics Inc. | 1.29M | US$3.21M | 0.57% |
| Cue Biopharma, Inc. | 109K | US$2.81M | 0.50% |
| United Therapeutics Corporation | 4,646 | US$2.52M | 0.45% |
| Dyne Therapeutics, Inc. | 154K | US$2.48M | 0.44% |
| Attovia Therapeutics, Inc. | 138K | US$2.37M | 0.42% |
| Oruka Therapeutics, Inc. | 27,260 | US$2.27M | 0.41% |
| Insmed Incorporated | 19,603 | US$2.24M | 0.40% |
| GeneDx Holdings Corp. | 29,275 | US$2.12M | 0.38% |
| Whitehawk Therapeutics, Inc. | 496K | US$1.86M | 0.33% |
| Monopar Therapeutics Inc. | 23,302 | US$1.86M | 0.33% |
| Helix Acquisition Corp. III | 172K | US$1.82M | 0.33% |
| Arcutis Biotherapeutics, Inc. | 61,189 | US$1.62M | 0.29% |
| TCGX Acquisition Corp. | 100K | US$1.25M | 0.22% |
| SAB Biotherapeutics, Inc. | 353K | US$1.12M | 0.20% |
| JATT III Acquisition Corp | 100K | US$1.1M | 0.20% |
| Quoin Pharmaceuticals. Ltd | 236K | US$1.08M | 0.19% |
| ADARx Pharmaceuticals, Inc. | 52,000 | US$1.04M | 0.19% |
| The Oncology Institute, Inc. | 157K | US$990K | 0.18% |
| Cellectar Biosciences, Inc. | 447K | US$823K | 0.15% |
| Alto Neuroscience, Inc. | 21,763 | US$556K | 0.10% |
| Braveheart Bio, Inc. | 10,000 | US$202K | 0.04% |
| Relmada Therapeutics, Inc. | 44,129 | US$166K | 0.03% |
| Vistagen Therapeutics, Inc. | 338K | US$24,716 | <0.01% |
| Solid Biosciences Inc. | 0 | US$0 | 0.00% |
| Spruce Biosciences, Inc. | 0 | US$0 | 0.00% |
| Tenax Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| Zura Bio Limited | 0 | US$0 | 0.00% |
| ACADIA Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Alumis Inc. | 0 | US$0 | 0.00% |
| Amylyx Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Assembly Biosciences, Inc. | 0 | US$0 | 0.00% |
| Axsome Therapeutics, Inc. | 0 | US$0 | 0.00% |
| BioAge Labs, Inc. | 0 | US$0 | 0.00% |
| CalciMedica, Inc. | 0 | US$0 | 0.00% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Climb Bio, Inc. | 0 | US$0 | 0.00% |
| Crescent Biopharma, Inc. | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Definium Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Equillium, Inc. | 0 | US$0 | 0.00% |
| EyePoint, Inc. | 0 | US$0 | 0.00% |
| Inventiva SA | 0 | US$0 | 0.00% |
| Kodiak Sciences Inc | 0 | US$0 | 0.00% |
| MapLight Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Monte Rosa Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Personalis, Inc. | 0 | US$0 | 0.00% |
| Protagonist Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Rapport Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |